NCT02183376View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

March 31, 2009

Conditions
Hepatic Insufficiency
Interventions
DRUG

BI 1356

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY